Black Rock Inc. Acumen Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,158,661 shares of ABOS stock, worth $3.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,158,661

Previous 189,697 1037.95%

Holding current value

$3.84 Million

Previous $768,000 580.08%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.14 - $4.01 $4.21 Million - $7.9 Million	1,968,964 Added 1037.95%	2,158,661 $5.22 Million
Q1 2024 May 10, 2024	SELL	$2.97 - $4.64 $173,442 - $270,966	-58,398 Reduced 23.54%	189,697 $768,000
Q4 2023 Feb 13, 2024	SELL	$1.86 - $4.48 $623,693 - $1.5 Million	-335,319 Reduced 57.48%	248,095 $952,000
Q3 2023 Nov 13, 2023	BUY	$4.15 - $9.72 $415,373 - $972,874	100,090 Added 20.71%	583,414 $2.42 Million
Q2 2023 Aug 11, 2023	SELL	$3.59 - $6.59 $676,022 - $1.24 Million	-188,307 Reduced 28.04%	483,324 $2.32 Million
Q1 2023 May 12, 2023	SELL	$3.75 - $6.65 $1.77 Million - $3.15 Million	-473,056 Reduced 41.33%	671,631 $2.73 Million
Q4 2022 Feb 13, 2023	BUY	$4.81 - $10.17 $142,664 - $301,642	29,660 Added 2.66%	1,144,687 $6.18 Million
Q3 2022 Nov 14, 2022	SELL	$4.44 - $10.48 $7.01 Million - $16.5 Million	-1,578,284 Reduced 58.6%	1,115,027 $11.2 Million
Q2 2022 Aug 12, 2022	SELL	$3.08 - $4.88 $3.51 Million - $5.55 Million	-1,138,010 Reduced 29.7%	2,693,311 $12.7 Million
Q1 2022 May 12, 2022	BUY	$3.91 - $6.73 $2.82 Million - $4.86 Million	721,651 Added 23.21%	3,831,321 $15 Million
Q4 2021 Feb 10, 2022	BUY	$6.54 - $15.31 $1.58 Million - $3.69 Million	240,879 Added 8.4%	3,109,670 $21 Million
Q3 2021 Nov 09, 2021	BUY	$14.5 - $20.28 $41.6 Million - $58.2 Million	2,868,791 New	2,868,791 $42.6 Million

Others Institutions Holding ABOS

# of Institutions

Shares Held

38.8M

Call Options Held

31.5K

Put Options Held

View Full List

About Acumen Pharmaceuticals, Inc.

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $72.1M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

More about ABOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account